• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia.

作者信息

Hughes I A, Read G F

出版信息

Horm Res. 1982;16(2):100-6. doi: 10.1159/000179489.

DOI:10.1159/000179489
PMID:7106698
Abstract

The mean age at menarche in 6 girls on treatment for congenital adrenal hyperplasia from infancy was 13.6 years (range 12.6-14.5 years). Menarche or regular menses did not occur until plasma testosterone concentrations were within normal limits. This was achieved using single daily dexamethasone, 0.25-0.75 mg/day. The potency of this glucocorticoid in suppressing adrenal steroid biosynthesis relative to cortisol is about 80:1. The onset of regular, ovulatory menstrual cycles, as judged by daily salivary progesterone profiles, was achieved within 2-3 years of menarche using this treatment regimen. Such patients have a good prognosis for normal fertility.

摘要

相似文献

1
Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia.
Horm Res. 1982;16(2):100-6. doi: 10.1159/000179489.
2
Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience.
Clin Endocrinol (Oxf). 1997 Mar;46(3):327-32. doi: 10.1046/j.1365-2265.1997.1360962.x.
3
Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency.通过唾液采样监测21-羟化酶缺乏症女性患者的月经周期、排卵和肾上腺抑制情况。
Fertil Steril. 2003 Oct;80(4):1030-6. doi: 10.1016/s0015-0282(03)01006-9.
4
The use of salivary progesterone assays in the assessment of ovarian function in postmenarcheal girls.唾液孕酮检测在初潮后女孩卵巢功能评估中的应用。
J Endocrinol. 1984 Aug;102(2):265-8. doi: 10.1677/joe.0.1020265.
5
Adolescent menstrual irregularity.青少年月经不规律。
J Reprod Med. 1984 Jun;29(6):399-410.
6
Monitoring treatment in congenital adrenal hyperplasia. Use of serial measurements of 17-OH-progesterone in plasma, capillary blood, and saliva.先天性肾上腺皮质增生症的治疗监测。血浆、毛细血管血和唾液中17-羟孕酮的系列测量应用。
Ann N Y Acad Sci. 1985;458:193-202. doi: 10.1111/j.1749-6632.1985.tb14604.x.
7
Treatment of menstrual irregularities with dexamethasone in congenital adrenal hyperplasia.先天性肾上腺皮质增生症中地塞米松治疗月经不调
J Adolesc Health Care. 1981 Sep;2(1):23-7. doi: 10.1016/s0197-0070(81)80081-2.
8
Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.糖皮质激素在先天性肾上腺皮质增生症中的疗效差异
Pediatrics. 1976 Jun;57(6):942-7.
9
The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia.长效糖皮质激素对男性化先天性肾上腺皮质增生症患者月经异常的影响。
J Clin Endocrinol Metab. 1978 Dec;47(6):1208-15. doi: 10.1210/jcem-47-6-1208.
10
Androstenedione rhythms in saliva in congenital adrenal hyperplasia.先天性肾上腺皮质增生症患者唾液中雄烯二酮的节律变化
Arch Dis Child. 1988 Jun;63(6):624-8. doi: 10.1136/adc.63.6.624.

引用本文的文献

1
Adrenal steroidogenesis and congenital adrenal hyperplasia.肾上腺类固醇生成与先天性肾上腺皮质增生症。
Endocrinol Metab Clin North Am. 2015 Jun;44(2):275-96. doi: 10.1016/j.ecl.2015.02.002.
2
Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency.在对受21-羟化酶缺乏影响的患者的护理中,骨骼健康应是一个重要关注点。
Int J Pediatr Endocrinol. 2010;2010. doi: 10.1155/2010/326275. Epub 2010 Sep 28.
3
Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the "growth toxic" glucocorticoid.
地塞米松治疗先天性肾上腺皮质增生症及“生长毒性”糖皮质激素的误区
Int J Pediatr Endocrinol. 2010;2010:569680. doi: 10.1155/2010/569680. Epub 2010 Apr 15.
4
Steroids and growth.类固醇与生长
Br Med J (Clin Res Ed). 1987 Sep 19;295(6600):683-4. doi: 10.1136/bmj.295.6600.683-a.
5
Management of congenital adrenal hyperplasia.先天性肾上腺皮质增生症的管理
Arch Dis Child. 1988 Nov;63(11):1399-404. doi: 10.1136/adc.63.11.1399.